ibuprofen has been researched along with Experimental Mammary Neoplasms in 8 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
Excerpt | Relevance | Reference |
---|---|---|
"Ibuprofen treatment reduced tumor volume (P < 0." | 1.30 | Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas. ( Abou-Issa, HM; Alshafie, G; Harris, RE; Joarder, FS; Parrett, ML; Robertson, FM; Ross, M, 1998) |
"Ibuprofen (IBU) was given intraperitoneally 10 mg/Kg dialy for 3 days to study the effects of cyclooxygenase blockade." | 1.28 | Cyclooxygenase inhibition with ibuprofen: effect on biodistribution of perflubron emulsions in mice with mammary tumor. ( Escobar, JA; Long, DM; Long, RA; Vasquez, F; Witt, BL, 1992) |
" These agents were tested either alone for the prevention of metastasis or in combination with IL-2 for the eradication of established metastasis." | 1.28 | Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2. ( Chan, FP; Khoo, NK; Lala, PK; Saarloos, MN, 1992) |
" In NMU cells, a linear dose-response inhibitory pattern was discernable, whereas in RBA cells a biphasic pattern was observed; PGE2 levels increased at low concentrations of ibuprofen and then decreased at higher concentrations." | 1.27 | Endogenous prostaglandin production by established cultures of neoplastic rat mammary epithelial cells. ( Cohen, LA; Karmali, RA, 1984) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (50.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, Q | 1 |
Minnier, J | 1 |
Burchard, J | 1 |
Chiotti, K | 1 |
Spellman, P | 1 |
Schedin, P | 1 |
Cohen, LA | 1 |
Karmali, RA | 3 |
Stratton, JA | 1 |
Braly, PS | 1 |
Rettenmaier, MA | 1 |
DiSaia, PJ | 1 |
Robertson, FM | 1 |
Parrett, ML | 1 |
Joarder, FS | 1 |
Ross, M | 1 |
Abou-Issa, HM | 1 |
Alshafie, G | 1 |
Harris, RE | 1 |
Long, DM | 1 |
Vasquez, F | 1 |
Witt, BL | 1 |
Escobar, JA | 1 |
Long, RA | 1 |
Khoo, NK | 1 |
Chan, FP | 1 |
Saarloos, MN | 1 |
Lala, PK | 1 |
Marsh, J | 2 |
8 other studies available for ibuprofen and Experimental Mammary Neoplasms
Article | Year |
---|---|
Physiologically activated mammary fibroblasts promote postpartum mammary cancer.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Female; Fibroblasts; Ibuprofe | 2017 |
Endogenous prostaglandin production by established cultures of neoplastic rat mammary epithelial cells.
Topics: Adenocarcinoma; Animals; Cell Division; Cell Line; Epithelium; Female; Ibuprofen; Mammary Neoplasms, | 1984 |
Depressed natural killer cell activity in tumor-bearing rats: effect of immunotherapy and cytoreductive chemotherapy.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adenocarcinoma; Adjuvants, Immunologic; Animals; Cisplatin; Cytot | 1983 |
Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents, Non-Steroidal; Female; Gene Exp | 1998 |
Cyclooxygenase inhibition with ibuprofen: effect on biodistribution of perflubron emulsions in mice with mammary tumor.
Topics: Animals; Contrast Media; Emulsions; Fluorocarbons; Hydrocarbons, Brominated; Ibuprofen; Mammary Neop | 1992 |
Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2.
Topics: Adenocarcinoma; Animals; Cell Division; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Female | 1992 |
Antitumor activity in a rat mammary adenocarcinoma: the effect of cyclooxygenase inhibitors and immunization against prostaglandin E2.
Topics: Animals; Antineoplastic Agents; Cyclooxygenase Inhibitors; Dinoprostone; Female; Flurbiprofen; Ibupr | 1986 |
Antitumor activity in a rat mammary adenocarcinoma: the effect of cyclooxygenase inhibitors and immunization against prostaglandin E2.
Topics: Adenocarcinoma; Animals; Antibodies; Antineoplastic Agents; Cell Line; Cyclooxygenase Inhibitors; Di | 1985 |